Cargando…

Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review

Curcumin has anti-inflammatory, antioxidant, and anticancer effects and is used to treat diseases such as dermatological diseases, infection, stress, depression, and anxiety. J147, an analogue of curcumin, is designed and synthesized with better stability and bioavailability. Accumulating evidence d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Fang, Wang, Yanmei, Du, Yunbo, Zeng, Changchun, Liu, Yuqiang, Pan, Haobo, Ke, Changneng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481599/ https://www.ncbi.nlm.nih.gov/pubmed/37674139 http://dx.doi.org/10.1186/s12883-023-03358-5

Ejemplares similares

J147 ameliorates sepsis-induced depressive-like behaviors in mice by attenuating neuroinflammation through regulating the TLR4/NF-κB signaling pathway
por: Qiu, Fang, et al.
Publicado: (2023)

Nuclear spectroscopy of neutron rich A=147 nuclides: decay of /sup 147 /Cs, /sup 147/Ba and /sup 147/La
por: Shmid, M, et al.
Publicado: (1981)

The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
por: Prior, Marguerite, et al.
Publicado: (2013)

Manganese (II) Complex of 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid (NOTA) as a Hepatobiliary MRI Contrast Agent
por: Islam, Md. Kamrul, et al.
Publicado: (2023)

J147 Reduces tPA-Induced Brain Hemorrhage in Acute Experimental Stroke in Rats
por: Jin, Rong, et al.
Publicado: (2022)

Memorandum: experiment S147
por: CERN. Geneva. Electronic Experiments Committee
Publicado: (1975)

Repressing CD147 is a novel therapeutic strategy for malignant melanoma
por: Hu, Xing, et al.
Publicado: (2017)

In vivo astrocyte-to-neuron reprogramming for central nervous system regeneration: a narrative review
por: Talifu, Zuliyaer, et al.
Publicado: (2022)

J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox(™) Safety and Genotoxicity Analysis
por: Lapchak, Paul A., et al.
Publicado: (2013)

The Inhibitory Effect of Curcumin Derivative J147 on Melanogenesis and Melanosome Transport by Facilitating ERK-Mediated MITF Degradation
por: Lv, Jinpeng, et al.
Publicado: (2021)

CD147 deficiency is associated with impairedsperm motility/acrosome reaction and offersa therapeutic target for asthenozoospermia
por: Chen, Hao, et al.
Publicado: (2021)

Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeutics
por: Yurchenko, V, et al.
Publicado: (2010)

Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19
por: Liu, Chenglong, et al.
Publicado: (2020)

Superdeformed band in $^{147}$Tb
por: Nieminen, J M, et al.
Publicado: (1996)

147th SPSC Meeting
Publicado: (2022)

147th LHCC Meeting
Publicado: (2021)

Health Tract, No. 147: Dieting
Publicado: (1863)

Health Tract, No. 147: Dieting
Publicado: (1865)

Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review
por: Won, Seoyeon, et al.
Publicado: (2023)

Lattice location of implanted $^{147}$Nd and $^{147*}$Pm in GaN using emission channeling
por: De Vries, B, et al.
Publicado: (2003)

Low-spin states of $^{147}_{64}$Gd$_{83}$ in the $\beta$-decay of $^{147g}$Tb
por: Wawryszczuk, J, et al.
Publicado: (1996)

Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)
por: Sehirli, Ahmet Ozer, et al.
Publicado: (2020)

Triaqua(1,4,7-triazacyclononane-κ(3) N (1),N (4),N (7))nickel(II) bromide nitrate
por: Wen, Changchun, et al.
Publicado: (2010)

Delivery of Therapeutic Agents to the Central Nervous System and the Promise of Extracellular Vesicles
por: René, Charlotte A., et al.
Publicado: (2021)

Observation and Nursing of Adverse Reactions in Severe Patients with Enhanced MRI
por: Dai, Yehua, et al.
Publicado: (2022)

Research advances in airway remodeling in asthma: a narrative review
por: Huang, Yanmei, et al.
Publicado: (2022)

Minutes of the 147th Meeting of the LHCC
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2021)

Corrigendum to: Identification of a Hemolysis Threshold That Increases Plasma and Serum Zinc Concentration. J Nutr 147;6: 1218–25
Publicado: (2021)

A case of concentrated growth factor gel to fill the defect after large jaw cyst enucleation
por: Chen, Binxiong, et al.
Publicado: (2023)

Can CD147 work as a therapeutic target for tumors through COVID-19 infection?
por: Ren, Hao-Lin, et al.
Publicado: (2022)

P147: Assessing the thoroughness of hand hygiene: “To see is to believe”
por: Chen, Y-C, et al.
Publicado: (2013)

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
por: LoVerde, Philip T., et al.
Publicado: (2022)

The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature
por: Xiong, Lijuan, et al.
Publicado: (2014)

Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review
por: Palaiodimou, Lina, et al.
Publicado: (2023)

Dealing with the family: CD147 interactions with cyclophilins
por: Yurchenko, Vyacheslav, et al.
Publicado: (2006)

Favoured neutron excitations in superdeformed $^{147}$Gd
por: Theisen, C, et al.
Publicado: (1995)

Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system
por: Wang, Qinghua, et al.
Publicado: (2021)

Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents
por: Onoda, Toshihisa, et al.
Publicado: (2014)

The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review
por: Carrara, Marta, et al.
Publicado: (2021)

Current and developing therapeutic agents in the treatment of Chagas disease
por: Apt, Werner
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dv3pe9p0fab4dmb2hvjoodug3k